Physician profile
Brian S Cooper
NPI 1134286792
$5,670.69
in general payments reported to CMS, 2019-2025
24 companies · $1,955 in 2025
The $1,955 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $1,352 · 2021: $92.67 · 2022: $457 · 2023: $586 · 2024: $592 · 2025: $1,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102 · Travel and Lodging: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.88 |
| Travel and Lodging | $1,031.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,881.94 | 2019-2025 | General - Therapies, Rhythmia Mapping System, Emblem Mri S-Icd |
| Medtronic Vascular, INC. | $900.89 | 2020 | |
| Abbott Laboratories | $529.77 | 2019-2025 | Ensite, Aveir, Assurity |
| Novartis Pharmaceuticals Corporation | $410.76 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $327.92 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $311.03 | 2019-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $299.88 | 2019-2023 | Xarelto |
| Cardiofocus, INC. | $246.93 | 2022-2023 | Heartlight System |
| Biotronik INC. | $144.96 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $131.16 | 2019-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $117.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $95.07 | 2019-2024 | |
| Pfizer INC. | $53.08 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.35 | 2023 | Jardiance |
| Medtronic, INC. | $30.06 | 2025 | Linq II |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celonova Biosciences, INC. | $26.75 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.42 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $19.32 | 2024 | Uptravi, Opsumit |
| Cardiva Medical, INC. | $17.95 | 2025 | Cardiva Vascade 5f Vcs |
| Philips North America LLC | $16.84 | 2023 | |
| Medline Industries LP | $16.00 | 2024 | |
| Amgen INC. | $15.49 | 2020 | |
| Altathera Pharmaceuticals LLC | $14.44 | 2023 | Sotalol Hydrochloride |
| Kowa Pharmaceuticals America, INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.